Insight Molecular Diagnostics (IMDX) Equity Income (2020 - 2021)
Insight Molecular Diagnostics' (IMDX) quarterly Equity Income came in at -$270000.0 in Q1 2021, up 17.93% year-on-year from -$228943.3 in Q1 2020, and up 37.93% quarter-over-quarter from -$435000.0 in Q4 2020.
Insight Molecular Diagnostics (IMDX) Equity Income (2020 - 2021) Analysis & Trends
Insight Molecular Diagnostics has disclosed Equity Income across 2 years of filings, most recently posting -$270000.0 for Q1 2021.
- Equity Income for Q1 2021 came in at -$270000.0, up 17.93% year-over-year; the trailing twelve-month figure through Dec 2021 was -$270000.0 (up 82.55% YoY), and the FY2021 annual result was -$270000.0, up 82.55% from the prior year.
- Equity Income came in at -$270000.0 for Q1 2021 at Insight Molecular Diagnostics, up from -$435000.0 in the prior quarter.
- In the past five years, Equity Income ranged from a high of -$270000.0 in Q1 2021 to a low of -$482000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | -8.00 Mn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | - |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | - |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 6.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | - |
| 10 | Insight Molecular Diagnostics | 4.52 Mn | -24.41 Mn | 15,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -270,000.00 |
| Dec 31, 2020 | -435,000.00 |
| Sep 30, 2020 | -482,000.00 |
| Jun 30, 2020 | -301,000.00 |
| Mar 31, 2020 | -329,000.00 |